Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer

Immunotherapy
Bernard BizziniMarie-Christophe Boissier

Abstract

The complex homeostasis of tissues is coordinated by the cytokine network and imbalances in this network may result in chronic immune disorders. Key specific cytokines, such as TNF-alpha, IFN-alpha, IL-4 or VEGF have been demonstrated to be overproduced or abnormally released in the microenvironment of pathologic tissues. These findings have opened up the way to passive immunotherapy with anticytokine monoclonal antibodies. Even though passive immunotherapy has proved to be efficient, it is hampered by specific limitations. The discovery of a family of immunogens, the kinoids, consisting of inactivated cytokine derivatives, has led some to propose them for active immunotherapy as an alternative to passive immunotherapy. This review focuses on kinoids - on their validation in experimental mouse models and ongoing clinical trials. The advantages offered by this active immune therapy in terms of efficacy, safety and patient compliance will be stressed.

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Feb 1, 1992·AIDS Research and Human Retroviruses·M L FrancisH E Gendelman
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J KekowM Lotz
Feb 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J Y LauR Williams
Nov 1, 1991·Science·R KühnW Müller
Dec 1, 1968·The Journal of Allergy·K Ishizaka, T Ishizaka
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Sep 1, 1994·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M Ricci
Oct 1, 1993·AIDS Research and Human Retroviruses·M R CapobianchiF Dianzani
Aug 19, 1993·International Journal of Cancer. Journal International Du Cancer·G A GastlN H Bander
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·D ZaguryR C Gallo
Jun 24, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G GonzálezA Lage
Sep 2, 1998·The Journal of Allergy and Clinical Immunology·J E de Vries
Nov 12, 1998·The American Journal of Pathology·T TobeP A Campochiaro
Jan 28, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H Le BuanecA Gringeri
Mar 30, 1999·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·A GringeriD Zagury
May 25, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D ZaguryA Gringeri
Nov 2, 1999·Micron : the International Research and Review Journal for Microscopy·J R Harris, J Markl
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·M RichardJ Van Snick
Feb 1, 2000·Immunology Today·I ShirakawaJ M Hopkin
Nov 30, 2000·The New England Journal of Medicine·P E LipskyUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Apr 20, 2001·Cytokine & Growth Factor Reviews·P C SmithE T Keller
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·D ZaguryR C Gallo
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M HertzA Gautam
Nov 6, 2001·Oncology·C L VogelS J Stewart
Apr 3, 2002·Seminars in Cancer Biology·Alain P VicariGiorgio Trinchieri
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group

❮ Previous
Next ❯

Citations

Apr 30, 2013·Médecine sciences : M/S·Catherine Uyttenhove, Jacques van Snick
Mar 10, 2011·Expert Opinion on Biological Therapy·Luca SemeranoMarie-Christophe Boissier
Sep 28, 2016·BMC Immunology·Yunier Rodríguez-ÁlvarezAlicia Santos-Savio

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
transgenic
chemical treatment

Clinical Trials Mentioned

NCT00808262
NCT00809783
NCT00043706
NCT00924105
NCT00017693
NCT00410280
NCT00433875
NCT00443326
NCT00966875
NCT00930683

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.